β-Elemene, a novel plant-derived antineoplastic agent, increases cisplatin chemosensitivity of lung tumor cells by triggering apoptosis

Qingdi Q. Li, Gangduo Wang, Manchao Zhang, Christopher F. Cuff, Lan Huang, Eddie Reed

Research output: Contribution to journalArticle

70 Citations (Scopus)

Abstract

β-Elemene, a new plant-derived anticancer agent with low toxicity, has been reported to be effective in the treatment of leukemia and solid tumors. In the current study, we explored the therapeutic application of β-elemene in sensitizing lung cancer cells to cisplatin. β-Elemene considerably enhanced the inhibitory effect of cisplatin on cell proliferation in a time- and dose-dependent manner in the human non-small cell lung cancer (NSCLC) cell lines H460 and A549. Furthermore, this effect of β-elemene on cisplatin activity occurred through the induction of apoptosis in NSCLC cells, as assessed by an ELISA-based assay, TUNEL assay and annexin V binding assay. Consistent with these results, the protein levels of Bax and phospho-Bcl-2 increased and those of Bcl-2 and XIAP decreased in cells treated with β-elemene in combination with cisplatin, compared with the levels in cells treated with either agent alone. Finally, β-elemene augmented the cisplatin-induced increases in caspase-3, -7, -9 and -10 activities and cleaved caspase-3, -9 and poly(ADP-ribose) polymerase levels in NSCLC cells. These observations suggest that β-elemene sensitizes NSCLC cells to cisplatin via a mitochondria-mediated intrinsic apoptosis pathway involving Bcl-2 family proteins and IAPs (inhibitor of apoptosis proteins). Our data provide a rationale for developing a combination of β-elemene and cisplatin as a regimen for the treatment of lung carcinoma and other cisplatin-resistant tumors.

Original languageEnglish (US)
Pages (from-to)161-170
Number of pages10
JournalOncology Reports
Volume22
Issue number1
DOIs
StatePublished - 2009
Externally publishedYes

Fingerprint

Antineoplastic Agents
Cisplatin
Apoptosis
Lung
Non-Small Cell Lung Carcinoma
Neoplasms
Caspase 3
Inhibitor of Apoptosis Proteins
Caspase 7
bcl-2-Associated X Protein
Poly(ADP-ribose) Polymerases
elemene
Caspase 9
Annexin A5
In Situ Nick-End Labeling
Lung Neoplasms
Mitochondria
Leukemia
Therapeutics
Enzyme-Linked Immunosorbent Assay

Keywords

  • β-elemene
  • Apoptosis
  • Chinese medicine
  • Cisplatin
  • Lung cancer
  • Plant drug

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

β-Elemene, a novel plant-derived antineoplastic agent, increases cisplatin chemosensitivity of lung tumor cells by triggering apoptosis. / Li, Qingdi Q.; Wang, Gangduo; Zhang, Manchao; Cuff, Christopher F.; Huang, Lan; Reed, Eddie.

In: Oncology Reports, Vol. 22, No. 1, 2009, p. 161-170.

Research output: Contribution to journalArticle

Li, Qingdi Q. ; Wang, Gangduo ; Zhang, Manchao ; Cuff, Christopher F. ; Huang, Lan ; Reed, Eddie. / β-Elemene, a novel plant-derived antineoplastic agent, increases cisplatin chemosensitivity of lung tumor cells by triggering apoptosis. In: Oncology Reports. 2009 ; Vol. 22, No. 1. pp. 161-170.
@article{5a2c77021d924aa4aa4c2734d999321d,
title = "β-Elemene, a novel plant-derived antineoplastic agent, increases cisplatin chemosensitivity of lung tumor cells by triggering apoptosis",
abstract = "β-Elemene, a new plant-derived anticancer agent with low toxicity, has been reported to be effective in the treatment of leukemia and solid tumors. In the current study, we explored the therapeutic application of β-elemene in sensitizing lung cancer cells to cisplatin. β-Elemene considerably enhanced the inhibitory effect of cisplatin on cell proliferation in a time- and dose-dependent manner in the human non-small cell lung cancer (NSCLC) cell lines H460 and A549. Furthermore, this effect of β-elemene on cisplatin activity occurred through the induction of apoptosis in NSCLC cells, as assessed by an ELISA-based assay, TUNEL assay and annexin V binding assay. Consistent with these results, the protein levels of Bax and phospho-Bcl-2 increased and those of Bcl-2 and XIAP decreased in cells treated with β-elemene in combination with cisplatin, compared with the levels in cells treated with either agent alone. Finally, β-elemene augmented the cisplatin-induced increases in caspase-3, -7, -9 and -10 activities and cleaved caspase-3, -9 and poly(ADP-ribose) polymerase levels in NSCLC cells. These observations suggest that β-elemene sensitizes NSCLC cells to cisplatin via a mitochondria-mediated intrinsic apoptosis pathway involving Bcl-2 family proteins and IAPs (inhibitor of apoptosis proteins). Our data provide a rationale for developing a combination of β-elemene and cisplatin as a regimen for the treatment of lung carcinoma and other cisplatin-resistant tumors.",
keywords = "β-elemene, Apoptosis, Chinese medicine, Cisplatin, Lung cancer, Plant drug",
author = "Li, {Qingdi Q.} and Gangduo Wang and Manchao Zhang and Cuff, {Christopher F.} and Lan Huang and Eddie Reed",
year = "2009",
doi = "10.3892/or_00000420",
language = "English (US)",
volume = "22",
pages = "161--170",
journal = "Oncology Reports",
issn = "1021-335X",
publisher = "Spandidos Publications",
number = "1",

}

TY - JOUR

T1 - β-Elemene, a novel plant-derived antineoplastic agent, increases cisplatin chemosensitivity of lung tumor cells by triggering apoptosis

AU - Li, Qingdi Q.

AU - Wang, Gangduo

AU - Zhang, Manchao

AU - Cuff, Christopher F.

AU - Huang, Lan

AU - Reed, Eddie

PY - 2009

Y1 - 2009

N2 - β-Elemene, a new plant-derived anticancer agent with low toxicity, has been reported to be effective in the treatment of leukemia and solid tumors. In the current study, we explored the therapeutic application of β-elemene in sensitizing lung cancer cells to cisplatin. β-Elemene considerably enhanced the inhibitory effect of cisplatin on cell proliferation in a time- and dose-dependent manner in the human non-small cell lung cancer (NSCLC) cell lines H460 and A549. Furthermore, this effect of β-elemene on cisplatin activity occurred through the induction of apoptosis in NSCLC cells, as assessed by an ELISA-based assay, TUNEL assay and annexin V binding assay. Consistent with these results, the protein levels of Bax and phospho-Bcl-2 increased and those of Bcl-2 and XIAP decreased in cells treated with β-elemene in combination with cisplatin, compared with the levels in cells treated with either agent alone. Finally, β-elemene augmented the cisplatin-induced increases in caspase-3, -7, -9 and -10 activities and cleaved caspase-3, -9 and poly(ADP-ribose) polymerase levels in NSCLC cells. These observations suggest that β-elemene sensitizes NSCLC cells to cisplatin via a mitochondria-mediated intrinsic apoptosis pathway involving Bcl-2 family proteins and IAPs (inhibitor of apoptosis proteins). Our data provide a rationale for developing a combination of β-elemene and cisplatin as a regimen for the treatment of lung carcinoma and other cisplatin-resistant tumors.

AB - β-Elemene, a new plant-derived anticancer agent with low toxicity, has been reported to be effective in the treatment of leukemia and solid tumors. In the current study, we explored the therapeutic application of β-elemene in sensitizing lung cancer cells to cisplatin. β-Elemene considerably enhanced the inhibitory effect of cisplatin on cell proliferation in a time- and dose-dependent manner in the human non-small cell lung cancer (NSCLC) cell lines H460 and A549. Furthermore, this effect of β-elemene on cisplatin activity occurred through the induction of apoptosis in NSCLC cells, as assessed by an ELISA-based assay, TUNEL assay and annexin V binding assay. Consistent with these results, the protein levels of Bax and phospho-Bcl-2 increased and those of Bcl-2 and XIAP decreased in cells treated with β-elemene in combination with cisplatin, compared with the levels in cells treated with either agent alone. Finally, β-elemene augmented the cisplatin-induced increases in caspase-3, -7, -9 and -10 activities and cleaved caspase-3, -9 and poly(ADP-ribose) polymerase levels in NSCLC cells. These observations suggest that β-elemene sensitizes NSCLC cells to cisplatin via a mitochondria-mediated intrinsic apoptosis pathway involving Bcl-2 family proteins and IAPs (inhibitor of apoptosis proteins). Our data provide a rationale for developing a combination of β-elemene and cisplatin as a regimen for the treatment of lung carcinoma and other cisplatin-resistant tumors.

KW - β-elemene

KW - Apoptosis

KW - Chinese medicine

KW - Cisplatin

KW - Lung cancer

KW - Plant drug

UR - http://www.scopus.com/inward/record.url?scp=68249162541&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=68249162541&partnerID=8YFLogxK

U2 - 10.3892/or_00000420

DO - 10.3892/or_00000420

M3 - Article

C2 - 19513519

AN - SCOPUS:68249162541

VL - 22

SP - 161

EP - 170

JO - Oncology Reports

JF - Oncology Reports

SN - 1021-335X

IS - 1

ER -